T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.57B |
| 2 |
Elevance Health
ELV
|
+$1.16B |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$1.01B |
| 4 |
Royal Caribbean
RCL
|
+$860M |
| 5 |
AET
Aetna Inc
AET
|
+$790M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$1.76B |
| 2 |
Biogen
BIIB
|
+$1.47B |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$1.26B |
| 4 |
McKesson
MCK
|
+$1.2B |
| 5 |
Sherwin-Williams
SHW
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.75% |
| 2 | Consumer Discretionary | 14.84% |
| 3 | Financials | 13.9% |
| 4 | Technology | 11.11% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Meritage Homes
MTH
$4.8B
| $69.7M | 0.02% |
3,818,020
-1,238,340
| -24% | -$26.6M |
|
677
LCI Industries
LCII
$2.6B
| $69.4M | 0.02% |
1,270,160
-126,570
| -9% | -$7.14M |
|
|
AGU
678
DELISTED
Agrium
AGU
| $69.3M | 0.02% |
774,274
+708,069
| +1,070% | +$71.6M |
|
679
SPS Commerce
SPSC
$2.86B
| $69.2M | 0.02% |
2,037,204
-426,584
| -17% | -$14.9M |
|
680
Mativ Holdings
MATV
$667M
| $69.1M | 0.02% |
2,008,854
+63,515
| +3% | +$2.32M |
|
681
Chesapeake Utilities
CPK
$3.26B
| $68.6M | 0.02% |
1,292,462
+63,065
| +5% | +$3.21M |
|
|
HSNI
682
DELISTED
HSN, Inc.
HSNI
| $68.6M | 0.02% |
1,198,474
+48,280
| +4% | +$3.14M |
|
683
Helios Technologies
HLIO
$2.67B
| $68.4M | 0.02% |
2,489,740
+22,330
| +0.9% | +$732K |
|
|
ZU
684
DELISTED
ZULILY INC CLASS A COMMON STOCK
ZU
| $68M | 0.02% |
3,909,981
-493,641
| -11% | -$7.66M |
|
|
NBIS
685
Nebius Group N.V.
NBIS
$69.3B
| $67.9M | 0.02% |
6,329,293
+1,212,900
| +24% | +$15.8M |
|
686
Ionis Pharmaceuticals
IONS
$9.28B
| $67.8M | 0.02% |
1,677,543
+27,738
| +2% | +$1.44M |
|
687
Marvell Technology
MRVL
$199B
| $67.4M | 0.02% |
7,445,644
+1,592,082
| +27% | +$18.1M |
|
688
McGrath RentCorp
MGRC
$2.94B
| $67.3M | 0.02% |
2,521,600
-245,310
| -9% | -$6.54M |
|
689
National Bank Holdings
NBHC
$1.94B
| $66.5M | 0.01% |
3,241,140
+38,200
| +1% | +$790K |
|
690
Molson Coors Class B
TAP
$7.85B
| $66.5M | 0.01% |
801,508
+515,470
| +180% | +$37.3M |
|
691
Sempra
SRE
$56.5B
| $66.4M | 0.01% |
1,373,380
-25,550
| -2% | -$1.26M |
|
692
Dorman Products
DORM
$3.95B
| $66.3M | 0.01% |
1,303,710
-152,700
| -10% | -$7.65M |
|
|
RAI
693
DELISTED
Reynolds American Inc
RAI
| $66.3M | 0.01% |
1,497,984
+2,232
| +0.1% | +$92.6K |
|
|
ZSPH
694
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $66.1M | 0.01% |
1,006,253
-348,305
| -26% | -$20.9M |
|
695
PayPal
PYPL
$51.8B
| $65.3M | 0.01% |
+2,103,717
| New | +$75.4M |
|
|
AVX
696
DELISTED
AVX Corporation
AVX
| $65.2M | 0.01% |
4,982,202
+704,750
| +16% | +$9.18M |
|
697
Valmont Industries
VMI
$9.5B
| $64.7M | 0.01% |
681,814
-99,850
| -13% | -$10.9M |
|
|
LPNT
698
DELISTED
LifePoint Health, Inc.
LPNT
| $64.6M | 0.01% |
910,497
+3,570
| +0.4% | +$290K |
|
699
SM Energy
SM
$7.71B
| $64.5M | 0.01% |
2,013,135
+566,148
| +39% | +$20.5M |
|
700
Kroger
KR
$35.1B
| $64.3M | 0.01% |
1,783,708
-155,980
| -8% | -$5.78M |
|
Similar funds
T. Rowe Price Associates's Q3 2015 Portfolio in Review
As of Q3 2015, T. Rowe Price Associates held 2,618 positions worth $449B, down 7.6% from $486B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q3 2015 filing shows 86 new, 1,108 increased, 800 reduced and 108 closed positions. Its largest new stake was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M. The largest sale was Baidu, an estimated $1.76B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2015 buy was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M.
- T. Rowe Price Associates added most to Microsoft in Q3 2015, an estimated $1.57B increase.
- T. Rowe Price Associates's biggest Q3 2015 reduction was Baidu, cutting an estimated $1.76B.
- T. Rowe Price Associates fully exited HOSPIRA INC in Q3 2015, selling an estimated $988M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $449B portfolio in Q3 2015.
- T. Rowe Price Associates opened 86 new positions and closed 108 in Q3 2015.
- T. Rowe Price Associates's portfolio value fell 7.6% quarter-over-quarter to $449B.
Based on T. Rowe Price Associates's 13F filing for Q3 2015, filed 13 Nov 2015.